Drug induced rhabdomyolysis
Open Access
- 1 June 2012
- journal article
- review article
- Published by Elsevier in Current Opinion in Pharmacology
- Vol. 12 (3) , 335-339
Abstract
No abstract availableKeywords
Funding Information
- Austrian Science Foundation FWF (P-22385)
- Herzfeldersche Familienstiftung
This publication has 50 references indexed in Scilit:
- Facilitating adverse drug event detection in pharmacovigilance databases using molecular structure similarity: application to rhabdomyolysisJournal of the American Medical Informatics Association, 2011
- Hemolytic uremic syndrome and rhabdomyolysis in a patient with succinate coenzyme Q reductase (complex II) deficiencyClinical Nephrology, 2011
- Severe rhabdomyolysis during sunitinib treatment of metastatic renal cell carcinoma. A report of two casesAnnals of Oncology, 2010
- Sunitinib‐Induced Cardiotoxicity Is Mediated by Off‐Target Inhibition of AMP‐Activated Protein KinaseClinical and Translational Science, 2009
- Sunitinib-Induced Cardiotoxicity Is Mediated by Off-Target Inhibition of AMP-Activated Protein KinaseClinical and Translational Science, 2009
- Fatal rhabdomyolysis as a complication of ET-743 (Yondelis) chemotherapy for sarcoma: Case report and literature reviewCancer Biology & Therapy, 2007
- Safety, Pharmacokinetics, and Preliminary Antitumor Activity of Sorafenib: A Review of Four Phase I Trials in Patients with Advanced Refractory Solid TumorsThe Oncologist, 2007
- Rhabdomyolysis and acute renal failure in a patient treated with daptomycinJournal of Antimicrobial Chemotherapy, 2006
- Rhabdomyolysis: A reviewMuscle & Nerve, 2002
- Nifedipine Diminishes Exercise-Induced Muscle Damage in MouseInternational Journal of Sports Medicine, 1992